Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Amin, Alpesh N ^a   Lin, Jay ^b   Thompson, Stephen ^c   Wiederkehr, Daniel ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Novosys Health   (United States)

^c SANOFI   (France)

^d PFIZER INC   (United States)

Author keywords

Acute ischemic stroke; Care continuum; Deep vein thrombosis; Pulmonary embolism; Thromboprophylaxis

Indexed keywords

ENOXAPARIN; HEPARIN; WARFARIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; DEEP VEIN THROMBOSIS; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; CONTINUITY OF PATIENT CARE; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; STROKE; UNITED STATES; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84873422499     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-17     Document Type: Article

References (30)

1. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke 2001, 32:262-267. 10.1161/01.STR.32.1.262, 11136946.
2. Kelly J, Rudd A, Lewis RR, Coshall C, Moody A, Hunt BJ. Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 2004, 35:2320-2325. 10.1161/01.STR.0000140741.13279.4f, 15322298.
3. Kamphuisen PW, Agnelli G, Sebastianelli M. Prevention of venous thromboembolism after acute ischemic stroke. J Thromb Haemost 2005, 3:1187-1194. 10.1111/j.1538-7836.2005.01443.x, 15946209.
4. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke 1981, 12:474-477. 10.1161/01.STR.12.4.474, 7314170.
5. Brown M, Glassenberg M. Mortality factors in patients with acute stroke. JAMA 1973, 224:1493-1495. 10.1001/jama.1973.03220250017005, 4739951.
6. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Janzen RW, Rother J, Buecker-Nott HJ, Berger K, . German Stroke Registers Study Group Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 2004, 164:1761-1768. 10.1001/archinte.164.16.1761, 15364669, German Stroke Registers Study Group.
7. McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing 1986, 15:84-88. 10.1093/ageing/15.2.84, 3962762.
8. Turpie AG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Magnani HN, Hull RD, Gent M. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet 1987, 1:523-526.
9. Prins MH, Gelsema R, Sing AK, van Heerde LR, den Ottolander GJ. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis 1989, 19:245-250.
10. Hillbom M, Erilä T, Sotaniemi K, Tatlisumak T, Sarna S, Kaste M. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand 2002, 106:84-92. 10.1034/j.1600-0404.2002.01215.x, 12100367.
11. Diener HC, Ringelstein EB, von Kummer R, Landgraf H, Koppenhagen K, Harenberg J, Rektor I, Csányi A, Schneider D, Klingelhöfer J, Brom J, Weidinger G, . PROTECT Trial Group Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial. Stroke 2006, 37:139-144. PROTECT Trial Group.
12. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P, . American College of Chest Physicians Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 Suppl):630S-669S. American College of Chest Physicians.
13. Bergmann JF, Cohen AT, Tapson VF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Anderson FA, . ENDORSE Investigators Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost 2010, 103:736-748. 10.1160/TH09-09-0667, 20135072, ENDORSE Investigators.
14. Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: success or failure?. J Thromb Haemost 2007, 5:1610-1616. 10.1111/j.1538-7836.2007.02650.x, 17663733.
15. Amin A, Spyropoulos AC, Dobesh P, Shorr A, Hussein M, Mozaffari E, Benner JS. Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). J Thromb Thrombolysis 2010, 29:326-339. 10.1007/s11239-009-0361-z, 2837191, 19548071.
16. Zorowitz RD, Smout RJ, Gassaway JA, Horn SD. Prophylaxis for and treatment of deep venous thrombosis after stroke: the Post-Stroke Rehabilitation Outcomes Project (PSROP). Top Stroke Rehabil 2005, 12:1-10.
17. Burleigh E, Wang C, Foster D, Heller S, Dunn D, Safavi K, Griffin B, Smith J. Thromboprophylaxis in medically ill patients at risk for venous thromboembolism. Am J Health Syst Pharm 2006, 63(20 Suppl 6):S23-S29.
18. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 2007, 165:1-209.
19. Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo GF, . PREVAIL Investigators The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 2007, 369:1347-1355. 10.1016/S0140-6736(07)60633-3, 17448820, PREVAIL Investigators.
20. Viitanen M, Winblad B, Asplund K. Autopsy-verified causes of death after stroke. Acta Med Scand 1987, 222:401-408.
21. Dennis M, Sandercock PA, Reid J, Graham C, Murray G, Venables G, Rudd A, Bowler G, . CLOTS Trials Collaboration Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 2009, 373:1958-1965. 2692021, 19477503, CLOTS Trials Collaboration.
22. CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med 2010, 153:553-562. CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration.
23. Harvey RL, Lovell LL, Belanger N, Roth EJ. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: a historical cohort study. Arch Phys Med Rehabil 2004, 85:1070-1075. 10.1016/j.apmr.2003.09.012, 15241752.
24. Turpie AG, Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Chen M, Yusen RD, . EXCLAIM Investigators Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study. Stroke 2012, EXCLAIM Investigators.
25. The Joint Commission Venous Thromboembolism (VTE) Core Measure Set http://www.jointcommission.org/assets/1/6/Venous%20Thromboembolism.pdf, The Joint Commission.
26. U.S. Department of Health & Human Services. Centers for Medicare & Medicaid Services Hospital-Acquired Conditions (Present on Admission Indicator) http://www.cms.gov/HospitalAcqCond/01_Overview.asp#TopOfPage, U.S. Department of Health & Human Services. Centers for Medicare & Medicaid Services.
27. American Heart Association Get With The Guidelines-Stroke Toolbox http://www.heart.org/HEARTORG/HealthcareProfessional/GetWithTheGuidelinesHFStroke/GetWithTheGuidelinesStrokeHomePage/Get-With-The-Guidelines-Stroke-Toolbox_UCM_308030_Article.jsp, American Heart Association.
28. California Acute Stroke Pilot Registry Investigators The impact of standardized stroke orders on adherence to best practices. Neurology 2005, 65:360-365. California Acute Stroke Pilot Registry Investigators.
29. Hills NK, Johnston SC. Duration of hospital participation in a nationwide stroke registry is associated with improved quality of care. BMC Neurol 2006, 6:20. 10.1186/1471-2377-6-20, 1524807, 16740167.
30. Kleindorfer DO, Khoury J, Moomaw CJ, Alwell K, Woo D, Flaherty ML, Khatri P, Adeoye O, Ferioli S, Broderick JP, Kissela BM. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke 2010, 41:326-1331.